Zobrazeno 1 - 7
of 7
pro vyhledávání: ''
Autor:
Luis Puig, Jose Bernabeu-Wittel, Ignasi Gich, Monica Rios, María Teresa Montserrat-García, Eulalia Baselga, Fania Zamantta Muñoz-Garza, Esther Roé-Crespo
Publikováno v:
JAMA Dermatol
JAMA DERMATOLOGY
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
JAMA Dermatology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
JAMA DERMATOLOGY
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
JAMA Dermatology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
IMPORTANCE: Treatment of infantile hemangioma (IH) with topical timolol in the first 2 months of life (early proliferative phase) may prevent further growth and the need for treatment with oral propranolol. To our knowledge, no studies have determine
Autor:
Amit Maity, Alain H. Rook, Jennifer Villaseñor-Park, Carmela C. Vittorio, Kevin Zhang, Paul Haun, Sara A. Berg, Sara Samimi, Joanne Inverso, Daniel J. Lewis, Jaclyn Rosenthal, Christina A Del Guzzo, Ellen J. Kim, Maria Wysocka, Jessica E. Teague, Neha Jariwala, Bernice M. Benoit, Joseph S. Durgin, John P. Plastaras, Rachael A. Clark
Publikováno v:
JAMA Dermatol
Importance Sezary syndrome (SS) is an advanced form of cutaneous T-cell lymphoma with few long-term remissions observed. Objective To profile 3 patients with SS who have experienced long-term remission following the addition of low-dose total skin el
Publikováno v:
JAMA Dermatol
Importance Childhood-onset lupus erythematosus panniculitis (LEP) is a rare and chronic disfiguring disease. A paucity of literature exists on the clinical manifestations of this disease and how best to treat it. Objectives To describe the clinical f
Autor:
Carrie Diamond, Gabriele Richard, April Zhang, Dawn H. Siegel, Sabine Duchatelet, Anna Yasmine Kirkorian, India Hill, Nikita Lakdawala, Richard L. Tower, Kalyani Marathe, Alain Hovnanian, Flora Watanabe, Yaser Diab
Publikováno v:
JAMA Dermatol
Importance Olmsted syndrome is a rare and disabling genodermatosis for which no successful treatment is currently available. Objective To evaluate the clinical response to the mammalian target of rapamycin (mTOR) inhibitor sirolimus and/or the epider
Publikováno v:
JAMA Dermatol
Importance iPLEDGE is a rigorous program initiated in 2006 to reduce fetal exposure to isotretinoin, a disease-modifying medication for acne that carries a risk of teratogenesis. Despite the imposition of iPLEDGE requirements on patients and clinicia
Publikováno v:
JAMA Dermatology. 153:1302
Importance Brentuximab vedotin is a monomethyl auristatin E–conjugated monoclonal antibody directed against CD30. It represents a potential treatment for the CD30+lymphoproliferative disorder lymphomatoid papulosis (LyP), which currently has no app
Autor:
Kai-Lung Chen, Yung-Tsu Cho, Jau-Yu Liau, Yi-Shuan Sheen, Che-Wen Yang, Yu-Pin Cheng, Chia-Yu Chu
Publikováno v:
JAMA Dermatology. 153:906
Importance Purpuric skin lesions have only rarely been reported in patients receiving epidermal growth factor receptor inhibitors. However, their clinical and histopathologic presentations have varied considerably. Objective To characterize purpuric